[#item_full_content] The DEA has opened a new Schedule III registration process for state-licensed medical cannabis businesses, bringing manufacturers, distributors and labs into a federal controlled-substances framework. The shift also carries major tax implications, including relief from Section 280E for qualifying operators.
Read More